Precipio Diagnostics
New Haven
About Precipio Diagnostics
Precipio is a cancer diagnostics reference laboratory, delivering the latest in advanced diagnostics and personalized medicine. Our goal is to assist oncologists in providing the best care for their patients. At the intersection of academia, cancer research, and diagnostics, we connect physicians with world-renown pathologists at the Yale School of Medicine. At Precipio, our customers and their patients benefit from the most accurate, expert diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $3.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (May 2024)
- Ticker: nasdaq:PRPO
- Website: precipiodx.com
- Phone: (203)787-7888
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/precipio-diagnostics-136772 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.